|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1993-8-26
|
|
pubmed:abstractText |
At second-look surgical surveillance procedures, normal CA-125 levels can be associated with persistent disease in 50% to 60% of patients. A novel radioimmunoassay (RIA) has been evaluated for the ability to identify patients with persistent disease who have normal levels of CA-125.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1506-10
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:8336189-Animals,
pubmed-meshheading:8336189-Antibodies, Monoclonal,
pubmed-meshheading:8336189-Antigens, Neoplasm,
pubmed-meshheading:8336189-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:8336189-Female,
pubmed-meshheading:8336189-Glycoproteins,
pubmed-meshheading:8336189-Humans,
pubmed-meshheading:8336189-Mice,
pubmed-meshheading:8336189-Neoplasms,
pubmed-meshheading:8336189-Ovarian Diseases,
pubmed-meshheading:8336189-Ovarian Neoplasms,
pubmed-meshheading:8336189-Predictive Value of Tests,
pubmed-meshheading:8336189-Proteins,
pubmed-meshheading:8336189-Radioimmunoassay,
pubmed-meshheading:8336189-Reference Values,
pubmed-meshheading:8336189-Regression Analysis,
pubmed-meshheading:8336189-Reoperation,
pubmed-meshheading:8336189-Tumor Markers, Biological
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
|
|
pubmed:affiliation |
Duke University Medical Center, Durham, NC 27710.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
